Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.

Source:http://linkedlifedata.com/resource/pubmed/id/19822302

Download in:

View as

General Info

PMID
19822302